| 7026348 |
Indole sPLA2 inhibitors |
Edward David Mihelich, Alan M. Warshawsky |
2006-04-11 |
$261,008,000 |
| 6713645 |
Substituted tricyclics |
Nicholas J. Bach, Susan E. Draheim, Robert D. Dillard, Edward David Mihelich, Jason Scott Sawyer +17 more |
2004-03-30 |
$108,187,000 |
| 6608099 |
Indole sPLA2 inhibitors |
Edward David Mihelich, Alan M. Warshawsky |
2003-08-19 |
$152,467,000 |
| 6579871 |
Methods of using novel compounds as neuro-protective agents |
Jill A. Panetta, John Kevin Shadle, Lawrence Joseph Heinz, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2003-06-17 |
$179,653,000 |
| 6472387 |
Methods of using compounds as neuro-protective agents |
Jill A. Panetta, John Kevin Shadle, Lawrence Joseph Heinz, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2002-10-29 |
$136,068,000 |
| 6448396 |
Compounds useful as neuro-protective agents |
Benjamin Alan Anderson, Lawrence Joseph Heinz, Jill A. Panetta, John Allan Rieck, III, John Robert Rizzo +2 more |
2002-09-10 |
$109,326,000 |
| 6423709 |
Methods of using novel compounds as neuro-protective agents |
Jill A. Panetta, John Kevin Shadle, Lawrence Joseph Heinz, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2002-07-23 |
$360,199,000 |
| 6380213 |
Compounds useful as neuro-protective agents |
Jill A. Panetta, John Kevin Shadle, Lawrence Joseph Heinz, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2002-04-30 |
$98,315,000 |
| 6251928 |
Treatment of alzheimer's disease employing inhibitors of cathepsin D |
Jill A. Panetta, Jon K. Reel, John Kevin Shadle, Sandra K. Sigmund, Richard L. Simon +1 more |
2001-06-26 |
$203,013,000 |
| 6177440 |
Substituted tricyclics |
Nicholas J. Bach, Susan E. Draheim, Robert D. Dillard, Edward David Mihelich, Jason Scott Sawyer +17 more |
2001-01-23 |
$624,202,000 |
| 6166216 |
Compounds useful as neuro-protective agents |
Jill A. Panetta, John Kevin Shadle, Lawrence Joseph Heinz, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2000-12-26 |
$442,494,000 |
| 6156748 |
Compounds useful as neuro-protective agents |
Jill A. Panetta, John Kevin Shadle, Lawrence Joseph Heinz, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2000-12-05 |
$334,564,000 |
| 5981523 |
Compounds and methods for treating multiple sclerosis |
Jill A. Panetta |
1999-11-09 |
$103,079,000 |
| 5814646 |
Inhibitors of amyloid beta-protein production |
Lawrence Joseph Heinz, Jill A. Panetta, Jon K. Reel, John Kevin Shadle, Richard L. Simon +1 more |
1998-09-29 |
$221,221,000 |
| 5747517 |
Benzylidene rhodanines |
Jill A. Panetta, Jon K. Reel, John Kevin Shadle, Sandra K. Sigmund, Richard L. Simon +1 more |
1998-05-05 |
$134,602,000 |
| 5387690 |
Method of treating inflammatory bowel disease |
Jaswant S. Gidda, Jill A. Panetta |
1995-02-07 |
$60,959,000 |
| 5216002 |
Method of treating inflammatory bowel disease |
Jaswant S. Gidda, Jill A. Panetta |
1993-06-01 |
$24,788,000 |
| 4874782 |
Furanone derivatives |
Rosanne Bonjouklian, Christopher Meade, Edward David Mihelich |
1989-10-17 |
$14,287,000 |
| 4675390 |
2-deoxypentose derivatives |
Rosanne Bonjouklian |
1987-06-23 |
$14,882,000 |
| 4659859 |
2-alkoxy-1-alkoxy phosphoryl dichlorides |
Rosanne Bonjouklian |
1987-04-21 |
$9,711,000 |
| 4647685 |
2-alkoxy-1-((2-trialkylaminoethoxy)phosphinyloxy)-alkenes and alkynes, hydroxy inner salts |
Rosanne Bonjouklian |
1987-03-03 |
$21,020,000 |
